Xylem (NYSE:XYL) Reaches New 12-Month Low – Should You Sell?

Xylem Inc. (NYSE:XYL) hit a new 52-week low during trading on Friday . The stock traded as low as $108.57 and last traded at $109.2650, with a volume of 91803 shares. The stock had previously closed at $109.44.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on XYL. Robert W. Baird set a $161.00 target price on Xylem in a research note on Wednesday, February 11th. Oppenheimer reduced their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. JPMorgan Chase & Co. reduced their target price on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Barclays dropped their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Finally, Citigroup dropped their price target on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $152.77.

Xylem Stock Performance

The firm has a market capitalization of $26.03 billion, a price-to-earnings ratio of 27.25, a PEG ratio of 1.55 and a beta of 1.08. The company has a fifty day moving average of $120.83 and a two-hundred day moving average of $132.83. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. The business had revenue of $2.13 billion during the quarter, compared to analysts’ expectations of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the firm posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, equities research analysts predict that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem announced that its board has authorized a share repurchase plan on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its stock is undervalued.

Insiders Place Their Bets

In related news, Director Jerome A. Peribere bought 1,210 shares of the business’s stock in a transaction dated Monday, May 4th. The stock was purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the transaction, the director owned 27,209 shares in the company, valued at $3,172,841.49. The trade was a 4.65% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.32% of the company’s stock.

Institutional Trading of Xylem

Institutional investors have recently modified their holdings of the stock. Knuff & Co LLC bought a new stake in shares of Xylem during the 3rd quarter valued at $27,000. Wexford Capital LP bought a new stake in shares of Xylem during the 3rd quarter worth $27,000. Commonwealth Retirement Investments LLC bought a new stake in shares of Xylem during the 4th quarter worth $27,000. First Horizon Corp bought a new stake in shares of Xylem during the 3rd quarter worth $30,000. Finally, Ramirez Asset Management Inc. lifted its position in shares of Xylem by 100.0% during the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after buying an additional 100 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.